Oralna i maksilofacijalna kirurgija
Antikoagulantna terapija i reverzija antikoagulantnog učinka
Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants. (otvara se novi prozor)
Izvor: Br J Oral Maxillofac Surg 2014;52(3):e15-9.
Indeks: PubMed 24485810
DOI: 10.1016/j.bjoms.2014.01.006
https://www.ncbi.nlm.nih.gov/pubmed/24485810 (otvara se novi prozor)
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (otvara se novi prozor)
Izvor: J Thromb Haemost 2011;9(9):1705-12.
Indeks: PubMed 21729240
DOI: 10.1111/j.1538-7836.2011.04432.x
https://www.ncbi.nlm.nih.gov/pubmed/21729240 (otvara se novi prozor)
Emergency reversal of warfarin anticoagulation. (otvara se novi prozor)
Izvor: CMAJ 2010;182(18):2004.
Indeks: PubMed 21078740
DOI: 10.1503/cmaj.100983
https://www.ncbi.nlm.nih.gov/pubmed/21078740 (otvara se novi prozor)
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (otvara se novi prozor)
Izvor: Thromb Haemost 2012;108(2):217-24.
Indeks: PubMed 22627883
DOI: 10.1160/TH12-03-0179
https://www.ncbi.nlm.nih.gov/pubmed/22627883 (otvara se novi prozor)
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (otvara se novi prozor)
Izvor: Anesth Analg 2011;113(4):703-10.
Indeks: PubMed 21890888
DOI: 10.1213/ANE.0b013e318228c690
https://www.ncbi.nlm.nih.gov/pubmed/21890888 (otvara se novi prozor)